Oleogel-S10 is an effective and well-tolerated long-term treatment for epidermolysis bullosa, including patients with severe forms of the disease.

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they occur at the same time. Researchers addressed this issue by uncovering a new ...

A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they ...

The South Carolina Burn Center at the Medical University of South Carolina, the Zucker Institute for Innovation Commercialization, and Chitozan Health are hoping a new collaboration will revolutionize ...

Learn about the groundbreaking $1 bandage that generates its own electrical field to accelerate healing of chronic wounds.

BEIRUT – Israeli troops opened fire and wounded five people in south Lebanon on Jan 26, Lebanese media and security sources said, as residents sought to return to homes in the border area where ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...